Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization

Author： Cooke Catherine E.   Lee Helen Y.   Tong Yvette P.   Haines Stuart T.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.26, Iss.1, 2010-01, pp. : 231-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral antidiabetic agents in type 2 diabetes

By Levetan Claresa  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 945-952

Informa Healthcare

Access to resources Recommend Favorite

Successes and challenges of insulin therapy for type 2 diabetes in a managed-care setting

By Nichols Gregory A.   Gandra Shravanthi R.   Chiou Chiun-Fang   Anthony Mary S.   Alexander-Bridges Maria   Brown Jonathan B.  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 9-15

Informa Healthcare

Access to resources Recommend Favorite

Glycemic control and the first use of oral antidiabetic agents among patients with type 2 diabetes mellitus

By Mitchell Beth D.   Eby Elizabeth L.   Lage Maureen J.  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1587-1597

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular risks associated with second‐line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study

By  

DIABETIC MEDICINE, Vol. 32, Iss. 11, 2015-11 ,pp. : 1460-1469

John Wiley & Sons Inc

Access to resources Recommend Favorite

Are cholesterol levels being checked and managed appropriately in UK primary care type 2 diabetes?

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 11, 2015-11 ,pp. : 1389-1391

John Wiley & Sons Inc

Access to resources Recommend Favorite